SciTransfer
Organization

FUNDACION VASCA DE INNOVACION E INVESTIGACION SANITARIAS

Basque health innovation foundation specializing in medical device safety testing, open innovation testing beds, and nanotechnology-enabled diagnostics validation.

Research institutehealthES
H2020 projects
7
As coordinator
1
Total EC funding
€2.0M
Unique partners
101
What they do

Their core work

BIOEF is the Basque Foundation for Health Innovation and Research, based in Bilbao, Spain. They specialize in bridging the gap between medical technology development and regulatory safety — particularly for high-risk medical devices, in vitro diagnostics, and nanotechnology-enabled health products. They operate testing and validation infrastructure for medtech companies, run pre-commercial procurement processes for integrated care solutions, and support open innovation platforms that connect health technology developers with clinical environments. Their work sits at the intersection of health system needs and industrial medtech innovation.

Core expertise

What they specialise in

Medical device safety testing and validationprimary
3 projects

Core expertise demonstrated across TBMED (testing bed for high-risk devices), SAFE-N-MEDTECH (safety testing for nanotech medical devices, as coordinator), and PICCOLO (photonics endoscope).

Nanotechnology-enabled medical technologiesprimary
2 projects

Coordinated SAFE-N-MEDTECH focusing on safety testing across the lifecycle of nanoenabled medical technologies and in vitro diagnostics.

Open innovation and testing beds for medtechsecondary
3 projects

Participated in TBMED (Open Innovation Testing Bed), INNO4COV-19 (open innovation platform), and applied Quality by Design methodology.

Pre-commercial procurement for integrated careemerging
1 project

Carematrix PCP project addresses multimorbidity through pre-commercial procurement of integrated care solutions for aging populations.

Health data privacy and securityemerging
1 project

Involved in SOTERIA as third party, contributing to personal data protection, anonymization, and biometrics in health contexts.

Evolution & trajectory

How they've shifted over time

Early focus
Medical device testing and diagnostics
Recent focus
Integrated care and health data governance

BIOEF's early H2020 work (2016–2019) centered on clinical diagnostics and medical device development — endoscopy tools (PICCOLO), health data analytics (MIDAS), and safety testing infrastructure for devices. From 2019 onward, their focus broadened significantly: they moved into COVID-19 response platforms, pre-commercial procurement for elderly care, and health data privacy. The shift reveals a trajectory from pure medtech validation toward health system innovation — combining technology assessment with procurement models and data governance.

BIOEF is evolving from a medtech testing organization toward a health system innovation hub that combines device validation, procurement innovation, and data privacy — positioning them for Digital Health and personalized medicine consortia.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European21 countries collaborated

BIOEF primarily joins projects as a participant (5 of 7 projects), with one coordination role in SAFE-N-MEDTECH and two third-party contributions. This suggests they are a trusted specialist brought in for specific testing, validation, or regulatory expertise rather than a consortium architect. With 101 unique partners across 21 countries, they maintain a broad European network, indicating they are well-connected and easy to integrate into new consortia.

BIOEF has collaborated with 101 unique partners across 21 countries, forming a wide European network. As a Basque Country health research foundation, they connect Southern European clinical environments with Northern and Central European technology developers.

Why partner with them

What sets them apart

BIOEF occupies a rare niche: they combine health innovation research with hands-on testing infrastructure and regulatory pathway knowledge for medical devices. Unlike university labs focused on basic research or companies focused on product development, BIOEF bridges the two — offering open innovation testing beds where developers can validate high-risk devices under realistic conditions. Their public-sector foundation status in the Basque health system gives them direct access to clinical environments and procurement processes that private partners typically cannot reach.

Notable projects

Highlights from their portfolio

  • SAFE-N-MEDTECH
    Their only coordinator role — focused on safety testing for nanotechnology-enabled medical devices and in vitro diagnostics across their full lifecycle.
  • TBMED
    Largest single funding (EUR 999,446) — built an open innovation testing bed for high-risk medical device development using Quality by Design methodology.
  • Carematrix PCP
    Signals a strategic shift into pre-commercial procurement for integrated elderly care, combining health system reform with technology deployment.
Cross-sector capabilities
Digital health and health data platformsManufacturing — medical device testing and quality assuranceSecurity — health data privacy and anonymizationNanotechnology safety and regulation
Analysis note: Profile based on 7 projects (2016-2021), with two as third-party roles providing limited insight. Several early projects (MIDAS, PICCOLO) lack keyword data, so early-period characterization relies partly on project titles. The dual listing of SAFE-N-MEDTECH (as coordinator and third party) suggests an internal organizational structure where different units participate under different roles.